Cargando…
DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is highly prevailing in Asia and it is ranked in the most aggressive squamous cell carcinomas. High-frequency loss of heterozygosity occurred in chromosome 14q11.2 in many tumors including ESCC, suggesting that one or more tumor-suppressor genes might exist...
Autores principales: | Zhou, Y, Wang, L, Ban, X, Zeng, T, Zhu, Y, Li, M, Guan, X-Y, Li, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851108/ https://www.ncbi.nlm.nih.gov/pubmed/29106393 http://dx.doi.org/10.1038/onc.2017.383 |
Ejemplares similares
-
DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma
por: Luo, Xiangjian, et al.
Publicado: (2019) -
CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis
por: Dai, Xiyu, et al.
Publicado: (2023) -
DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKα to disrupt choline metabolism
por: Li, Zhenzhen, et al.
Publicado: (2022) -
STAMBPL1 promotes the progression of lung adenocarcinoma by inhibiting DHRS2 expression
por: Yang, Xiang, et al.
Publicado: (2023) -
Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells
por: Cheng, Xiao-Yu, et al.
Publicado: (2017)